STOCK TITAN
  1. Home
  2. Sec-filings
  3. NNVC
  4. [EFFECT] NANOVIRICIDES, INC. SEC Filing

[EFFECT] NANOVIRICIDES, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 19, 2025 4:30 P.M.
Form: S-3
CIK: 0001379006
Company Name: NANOVIRICIDES, INC.
File Number: 333-292142

Source: View Original Filing on SEC EDGAR

Nanoviricides

NYSE:NNVC

View NNVC Stock Overview →

NNVC Rankings

#6114 Ranked by Market Cap
N/A Ranked by Dividends

NNVC Latest News

Mar 11, 2026
NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete
Feb 12, 2026
MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Feb 10, 2026
Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Feb 2, 2026
NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres
Jan 13, 2026
NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave - NV-387 is Effective Against H3N2

NNVC Latest SEC Filings

Feb 17, 2026
[10-Q] NANOVIRICIDES, INC. Quarterly Earnings Report
Dec 30, 2025
[424B3] NANOVIRICIDES, INC. Prospectus Filed Pursuant to Rule 424(b)(3)
Dec 16, 2025
[DEL AM] NANOVIRICIDES, INC. SEC Filing
Dec 15, 2025
[S-3] NANOVIRICIDES, INC. Shelf Registration Statement
Nov 26, 2025
[8-K] NANOVIRICIDES, INC. Reports Material Event

NNVC Stock Data

20.52M
20.99M
Biotechnology
Pharmaceutical Preparations
Link
United States
SHELTON